Evoke (EVOK) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
12 Aug, 2026Executive summary
Delivered resilient first half performance with stable group revenue at £887.5m–£888m, up 2% like-for-like, despite significant increases in gaming duties, especially in the UK.
Adjusted EBITDA declined 9.5%–10% year-over-year to £150m–£150.2m, mainly due to a £46m rise in gaming duties, partially offset by operational efficiencies.
UK & I Online delivered strong growth, with revenue up 3.5%–4% and Adjusted EBITDA up 28%, driven by William Hill gaming and mitigation actions.
Retail profitability improved, with like-for-like revenue up 4% and Adjusted EBITDA up 5%, following the closure of approximately 270 shops.
International segment showed mixed results, with strong growth in Italy (+21%) and Denmark (+13%) offset by declines in Spain, Romania, and other markets, and higher duty costs.
Financial highlights
Group revenue was £887.5m–£888m, up 2% like-for-like year-over-year, despite 270 store closures.
Adjusted EBITDA was £150m–£150.2m, down 9.5%–10% year-on-year, reflecting higher gaming duties.
UK & I Online revenue up 3.5%–4% to £348.1m; Adjusted EBITDA up 28% to £77.0m.
International revenue down 1.9%–2% to £293.8m; Adjusted EBITDA down 20%–20.9% to £67.6m–£68.1m.
Retail revenue down 2.6%–3% to £245.6m; like-for-like revenue up 4%; Adjusted EBITDA up 5%–5.4% to £31.1m–£31.2m.
Outlook and guidance
Recommended acquisition by Bally's Intralot progressing as planned, with completion expected in Q4 2026 or Q1 2027, subject to approvals.
Continued focus on operational momentum, cash generation, and disciplined execution during the acquisition process.
No forward-looking financial guidance provided due to the pending acquisition.
Latest events from Evoke
- AGM focused on acquisition plans, improved 2025 results, and responses to UK regulatory changes.EVOK
AGM 2026 - Revenue and EBITDA rose, margins improved, and leverage fell amid strategic review and UK duty headwinds.EVOK
H2 2025 - FY25 revenue up 2%, EBITDA up 14-15%, with a strategic review amid UK tax hikes.EVOK
Q4 2025 TU - Revenue up 5% in Q3 2025, all divisions grew, and FY25 EBITDA margin guidance reaffirmed.EVOK
Q3 2025 TU - Strong revenue and EBITDA growth, improved margins, and significant deleveraging achieved.EVOK
H1 2025 - Revenue down, losses widen, but transformation and H2 margin recovery on track.EVOK
H1 2024 - H2 revenue growth of 5-9% and margin recovery expected, driven by cost savings and innovation.EVOK
Trading Update - Business transformation, renewed growth, and enhanced governance were key AGM themes.EVOK
AGM 2025 - Growth resumed in 2024 with rising margins, strong core markets, and a clear deleveraging plan.EVOK
H2 2024